Numerous studies in recent years have revealed that the NF-κB pathway can regulate epithelial–mesenchymal transition (EMT) [34,35], influence the composition of the tumor microenvironment (TME) [36,37,38], and alter tumor resistance to chemotherapeutic drugs [39,40,41], thereby affecting tumor progression. This evidence concerns the gene NFKB1 and neoplasm.